Purchase Order 75D30119P04862
- Not listed
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm-fixed-price purchase order to Pacific Biosciences of California, Inc., a for-profit manufacturer of specialized scientific equipment, reagents, and services. The $357,500.00 contract is for the provision of Pacific Biosciences' Sequel system, which includes the Sequel DNA/RNA sequencing instrument and associated consumables. The contract has no set-aside designation and is to be performed in...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $193,000.00 firm fixed price purchase order to Pacific Biosciences of California, Inc. to upgrade their PacBio Sequel System. This contract does not have a set-aside designation. Pacific Biosciences is a manufacturer of specialized scientific equipment, reagents, and services associated with their Sequel and Sequel II DNA/RNA sequencing systems. They have fulfilled over $10 million in federal...
- This contract award is to Pacific Biosciences of California, Inc., a for-profit manufacturer, for the delivery of their Sequel and Sequel II DNA/RNA sequencing platforms and associated consumables to the Centers for Disease Control and Prevention (CDC). The $250,000.00 firm-fixed price purchase order has a performance period ending on December 31, 2025. Pacific Biosciences has established itself as a key supplier of specialized sequencing solutions to various federal agencies, as evidenced by...
- This federal contract award to Pacific Biosciences of California, Inc. is for DNA sequencer maintenance services. The $84,000.00 firm-fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) in Pittsburgh, Pennsylvania, a civilian agency. The contract has an ultimate completion date of January 13, 2019 and was awarded on January 14, 2018. Pacific Biosciences, a for-profit manufacturer, was selected without a set-aside designation, indicating they are the...
- The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a $165,103.00 firm fixed-price purchase order contract to Pacific Biosciences of California, Inc. (PacBio), a manufacturer of goods, for the provision of reagents. The contract has a completion date of September 30, 2023. PacBio is a prime contractor that has fulfilled over $10 million in federal contracts and delivery orders to provide sequencing instruments, consumables, and associated services...
- The Department of Health and Human Services Food and Drug Administration awarded a $433,950.00 firm fixed price purchase order to Pacific Biosciences of California, Inc. to provide a DNA sequencer with accessories. The contract has no set-aside designation and was completed on August 29, 2019. Pacific Biosciences is a manufacturer of specialized scientific equipment, reagents, and services for DNA/RNA sequencing. They have fulfilled over $10 million in federal contracts, including with the...
- This federal contract award to Pacific Biosciences of California, Inc. is for the provision of supplies related to SMRT sequencing technology. The $142,982.42 firm fixed price purchase order was issued by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services and has a period of performance ending on March 31, 2016. Pacific Biosciences is the original equipment manufacturer for their proprietary Sequel and Sequel II DNA/RNA sequencing platforms, which are utilized by...
- This federal contract award, valued at $84,000.00, was issued by the Centers for Disease Control and Prevention (CDC) to Pacific Biosciences of California, Inc. for a service agreement related to their Pacific Biosciences RS DNA Sequencer. The contract is a firm fixed-price purchase order without a set-aside designation. Pacific Biosciences is the original equipment manufacturer of the Sequel and Sequel II DNA/RNA sequencing platforms, which are utilized by various federal agencies to support...
- This is a firm fixed-price purchase order issued by the Department of Health and Human Services Food and Drug Administration to Pacific Biosciences of California, Inc., a small business manufacturer of specialized scientific equipment, reagents, and services. The $175,000.00 contract provides a service and maintenance agreement for Pacific Biosciences' Sequel and Sequel II DNA/RNA sequencing systems, including software updates and annual preventative maintenance visits. Pacific Biosciences has...
- This contract is a Blanket Purchase Agreement (BPA) call awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Pacific Biosciences of California, Inc., a manufacturer of specialized scientific equipment, reagents, and services associated with their Sequel and Sequel II DNA/RNA sequencing systems. The contract has a potential value of $168,880.71 and is for the delivery of sequencing instruments, consumables, and associated services to support...
This contract was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Pacific Biosciences of California, Inc. for laboratory equipment maintenance services for the agency's PacBio RSII and Sequel DNA sequencing systems. The $119,000 firm fixed-price purchase order has a completion date of September 18, 2020. Pacific Biosciences is a manufacturer of specialized scientific equipment, reagents, and sequencing services that has fulfilled over $10 million in federal contracts with agencies such as the Department of Agriculture, Department of Health and Human Services, Food and Drug Administration, National Institutes of Health, and Department of Defense. The company holds Indefinite Delivery Indefinite Quantity contracts to provide sequencing instruments, consumables, and associated services to support genomic research initiatives across the government. This award was not set aside for a specific business category.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Other Administrative Action | ($42k) | 6/26/23 | |
| Not listed | Not listed | $119.0k | 4/26/19 |